logo
logo

London Biotech Baseimmune Closes £3.5M Funding, Eyes To Develop Future-Proof Universal Vaccines

Nov 02, 2021•over 3 years ago

Amount Raised

£3.5 Million

Round Type

seed

London

Description

The COVID-19 pandemic has fuelled a renaissance in vaccine research, underpinned by the creation of novel vaccine delivery systems and robust worldwide manufacturing pipelines, with the global vaccine market predicted to reach $108 billion by 2027.

Company Information

Company

Baseimmune

Location

London, Ontario, Canada

About

The proceeds of this round will be enable the company to grow, develop more vaccines in parallel and further expanding the number of diseases it is able to tackle.